As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antiviral Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 24416773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells.

  2013cited by this paper
• Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation.

  2013cited by this paper
• Transcriptional Control of HIV Replication by Multiple Modulators and Their Implication for a Novel Antiviral Therapy

  2012cited by this paper
• The development of immune-modulating compounds to disrupt HIV latency.

  2012cited by this paper
• Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication

  2012cited by this paper
• Arsenic Trioxide Exerts Antimyeloma Effects by Inhibiting Activity in the Cytoplasmic Substrates of Histone Deacetylase 6

  2012cited by this paper
• Systematic Identification of Synergistic Drug Pairs Targeting HIV

  2012cited by this paper
• Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB

  2012cited by this paper
• The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation

  2012cited by this paper
• HIV reservoirs and latency models.

  2011cited by this paper
• Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4+ T Cell Model without Inducing Global T Cell Activation

  2011cited by this paper
• Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms

  2011cited by this paper
• Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation

  2011cited by this paper
• The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit

  2011cited by this paper
• Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells.

  2010cited by this paper
• Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner

  2010cited by this paper
• Arsenic modulates APOBEC3G‐mediated restriction to HIV‐1 infection in myeloid dendritic cells

  2010cited by this paper
• Involvement of Histone H3 Lysine 9 (H3K9) Methyltransferase G9a in the Maintenance of HIV-1 Latency and Its Reactivation by BIX01294*

  2010cited by this paper
• Hit-and-Run Stimulation: a Novel Concept To Reactivate Latent HIV-1 Infection without Cytokine Gene Induction

  2010cited by this paper
• Cellular microRNA and P bodies modulate host-HIV-1 interactions.

  2009cited by this paper
• Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

  2009cited by this paper
• Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

  2009cited by this paper
• The Challenge of Finding a Cure for HIV Infection

  2009cited by this paper
• Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells*

  2009cited by this paper
• Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

  2008cited by this paper
• Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir

  2008cited by this paper
• Infected Cell Killing by HIV-1 Protease Promotes NF-κB Dependent HIV-1 Replication

  2008cited by this paper
• Eradication of HIV: current challenges and new directions.

  2008cited by this paper
• Identification of an Arsenic-Sensitive Block to Primate Lentiviral Infection of Human Dendritic Cells

  2007cited by this paper
• HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription

  2007cited by this paper
• Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

  2007cited by this paper
• Abnormal nuclear factor (NF)-kappaB signal pathway and aspirin inhibits tumor necrosis factor alpha-induced NF-kappaB activation in keloid fibroblasts.

  2007cited by this paper
• Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

  2007cited by this paper
• Arsenic Counteracts Human Immunodeficiency Virus Type 1 Restriction by Various TRIM5 Orthologues in a Cell Type-Dependent Manner

  2006cited by this paper
• The Yin and Yang of P-TEFb Regulation: Implications for Human Immunodeficiency Virus Gene Expression and Global Control of Cell Growth and Differentiation

  2006cited by this paper
• Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells

  2006cited by this paper
• Systems biology and combination therapy in the quest for clinical efficacy

  2006cited by this paper
• Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

  2005cited by this paper
• IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

  2005cited by this paper
• Inhibitors of DNA methylation: beyond myelodysplastic syndromes

  2005cited by this paper
• Low levels of arsenite activates nuclear factor‐κB and activator protein‐1 in immortalized mesencephalic cells

  2005cited by this paper
• Dual Role of Prostratin in Inhibition of Infection and Reactivation of Human Immunodeficiency Virus from Latency in Primary Blood Lymphocytes and Lymphoid Tissue

  2004cited by this paper
• Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis.

  2004cited by this paper
• Prostratin antagonizes HIV latency by activating NF-kappaB.

  2004cited by this paper
• Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression

  2004cited by this paper
• HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

  2003cited by this paper
• Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB

  2003cited by this paper
• p53-associated 3′→5′ exonuclease activity in nuclear and cytoplasmic compartments of cells

  2003cited by this paper
• As2O3 Enhances Retroviral Reverse Transcription and Counteracts Ref1 Antiviral Activity

  2003cited by this paper
• Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression.

  2002cited by this paper
• Mechanisms of action of arsenic trioxide.

  2002cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

  2000cited by this paper
• Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.

  2000cited by this paper
• The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.

  2000cited by this paper
• Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

  1999cited by this paper
• Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes.

  1999cited by this paper
• Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

  1999cited by this paper
• Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways.

  1999cited by this paper
• Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism.

  1998cited by this paper
• The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells.

  1997cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

  1997cited by this paper
• Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

  1997cited by this paper
• In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.

  1996cited by this paper
• Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

  1994cited by this paper
• Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-kappa B-independent mechanism.

  1993cited by this paper
• Cellular transcription factors involved in the regulation of HIV-1 gene expression.

  1992cited by this paper
• An inducible transcription factor activates expression of human immunodeficiency virus in T cells

  1990cited by this paper
• Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

  1989cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper
• Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

  1989cited by this paper

• Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation

  2023cites this paper
• Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques

  2023cites this paper
• Arsenic in medicine: past, present and future

  2022cites this paper
• Arsenic Trioxide Impacts Viral Latency and Delays Viral Rebound after Termination of ART in Chronically SIV‐Infected Macaques

  2019cites this paper
• Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells

  2018cites this paper
• Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus.

  2017cites this paper
• Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui

  2017cites this paper
• Advancements in Developing Strategies for Sterilizing and Functional HIV Cures

  2017cites this paper
• Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1

  2017cites this paper
• Elimination of cancer stem cells and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking inhibition of tumorigenesis and the potential eradication of HIV-1.

  2017cites this paper
• Quercetin synergistically reactivates human immunodeficiency virus type 1 latency by activating nuclear factor‑κB.

  2017cites this paper
• BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency

  2017cites this paper
• The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells

  2017cites this paper
• The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion

  2016cites this paper
• Oocyte activation and latent HIV-1 reactivation: AMPK as a common mechanism of action linking the beginnings of life and the potential eradication of HIV-1.

  2016cites this paper
• Specific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.

  2016cites this paper
• Molecular Mechanisms Controlling HIV Transcription and Latency – Implications for Therapeutic Viral Reactivation

  2016cites this paper
• The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb

  2016cites this paper
• Reactivation of latent HIV-1 in latently infected cells by coumarin compounds: Hymecromone and ScoparoneReactivation of Latent HIV-1 in Latently Infected Cells by Coumarin Compounds: Hymecromone and Scoparone.

  2016cites this paper
• Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options

  2015cites this paper
• Designed Transcription Activator-Like Effector Proteins Efficiently Induced the Expression of Latent HIV-1 in Latently Infected Cells

  2015cites this paper
• The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.

  2015cites this paper
• Oxaliplatin antagonizes HIV-1 latency by activating NF-κB without causing global T cell activation.

  2014cites this paper
• Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5′-LTR promoter

  2014cites this paper
• Dilazep synergistically reactivates latent HIV-1 in latently infected cells

  2014cites this paper